Clinical Trial Update: PSMA-specific CAR-T Cell Therapy [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial update for a PSMA-specific CAR-T cell therapy is underway for PSMA-positive tumors or tumor tissues.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Other Psma-expressing Solid Tumors
• Prostate Cancer

Drugs mentioned

• PSMA-specific CAR-T cell therapy

Snippet

Sponsor: Shenzhen Geno-Immune Medical Institute | Conditions: PSMA Positive Tumors or Tumor Tissues | Phase 1, Phase 2 | Status: UNKNOWN